Skip to Content

Insulin Aspart

In the US, Insulin Aspart (insulin aspart systemic) is a member of the drug class insulin and is used to treat Diabetes - Type 1 and Diabetes - Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10AB05,A10AD05,A10AD06

CAS registry number (Chemical Abstracts Service)

0116094-23-6

Chemical Formula

C256-H381-N65-O79-S6

Molecular Weight

5826

Therapeutic Categories

Antidiabetic agent

Insulin analogue, recombinant human

Chemical Name

28B-L-aspartic acid-insulin (human)

Foreign Names

  • Insulinum aspartum (Latin)
  • Insulin aspart (German)
  • Insuline asparte (French)
  • Insulina asparta (Spanish)

Generic Names

  • Insulin Aspart (OS: BAN, USAN)
  • Insulin Aspart (Genetical Recombination) (OS: JAN)
  • B28-Asp-Insulin (IS)
  • INA-X14 (IS)
  • Insulin X14 (IS)
  • Insulina asp├írtica (IS)
  • Insulin aspart (PH: Ph. Eur. 8)
  • Insulin Aspart (PH: BP 2015, USP 37)
  • Insulinum aspartum (PH: Ph. Eur. 8)

Brand Names

  • NovoLog
    Novo Nordisk, United States
  • Novomix
    Novo Nordisk, Lebanon; Novo Nordisk, Latvia
  • NovoMix 30 (30% sol./70% isoph.)
    Novo Nordisk, Georgia; Novo Nordisk, Portugal
  • NovoMix 50 (50% sol./50% isoph.)
    Novo Nordisk, Portugal
  • NovoMix 70 (70% sol./30% isoph.)
    Novo Nordisk, Portugal
  • NovoRapid
    Novo Nordisk, Austria; Novo Nordisk, Australia; Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Bangladesh; Novo Nordisk, Belgium; Novo Nordisk, Canada; Novo Nordisk, Switzerland; Novo Nordisk, Chile; Novo Nordisk, China; Novo Nordisk, Czech Republic; Novo Nordisk, Germany; Novo Nordisk, Denmark; Novo Nordisk, Egypt; Novo Nordisk, Spain; Novo Nordisk, Finland; Novo Nordisk, France; Novo Nordisk, United Kingdom; Novo Nordisk, Georgia; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Hungary; Novo Nordisk, Indonesia; Novo Nordisk, Ireland; Novo Nordisk, Israel; Novo Nordisk, India; Novo Nordisk, Iceland; Novo Nordisk, Italy; Novo Nordisk, Japan; Novo Nordisk, Lebanon; Novo Nordisk, Lithuania; Novo Nordisk, Latvia; Novo Nordisk, Mexico; Novo Nordisk, Malaysia; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, New Zealand; Novo Nordisk, Oman; Novo Nordisk, Philippines; Novo Nordisk, Portugal; Novo Nordisk, Romania; Novo Nordisk, Serbia; Novo Nordisk, Russian Federation; Novo Nordisk, Sweden; Novo Nordisk, Singapore; Novo Nordisk, Slovenia; Novo Nordisk, Thailand; Novo Nordisk, Tunisia; Novo Nordisk, Turkey; Novo Nordisk, Taiwan; Novo Nordisk, Vietnam; Novo Nordisk, South Africa; Roemmers, Colombia; Roemmers, Ecuador
  • Ryzodeg (Insulin Aspart and Insulin Degludec)
    Novo Nordisk, Switzerland; Novo Nordisk, Netherlands; Novo Nordisk, Portugal
  • NovoLog Mix 70/30 (70% aspart sol./30% aspart isoph.)
    Novo Nordisk, United States
  • NovoMix 30 (30% sol./70% isoph.)
    Novo Nordisk, Austria; Novo Nordisk, Australia; Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Bangladesh; Novo Nordisk, Belgium; Novo Nordisk, Canada; Novo Nordisk, Switzerland; Novo Nordisk, Chile; Novo Nordisk, China; Novo Nordisk, Czech Republic; Novo Nordisk, Germany; Novo Nordisk, Denmark; Novo Nordisk, Spain; Novo Nordisk, France; Novo Nordisk, United Kingdom; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Hungary; Novo Nordisk, Indonesia; Novo Nordisk, Ireland; Novo Nordisk, Israel; Novo Nordisk, India; Novo Nordisk, Iceland; Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Mexico; Novo Nordisk, Malaysia; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, New Zealand; Novo Nordisk, Oman; Novo Nordisk, Philippines; Novo Nordisk, Romania; Novo Nordisk, Serbia; Novo Nordisk, Russian Federation; Novo Nordisk, Sweden; Novo Nordisk, Singapore; Novo Nordisk, Slovenia; Novo Nordisk, Slovakia; Novo Nordisk, Thailand; Novo Nordisk, Tunisia; Novo Nordisk, Turkey; Novo Nordisk, Taiwan; Novo Nordisk, Vietnam; Novo Nordisk, South Africa
  • NovoMix 50
    Novo Nordisk, Austria
  • NovoMix 50 (50% sol./50% isoph.)
    Novo Nordisk, Australia; Novo Nordisk, Belgium; Novo Nordisk, Denmark; Novo Nordisk, Spain; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Israel; Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Netherlands; Novo Nordisk, Serbia; Novo Nordisk, Tunisia
  • NovoMix 70 (70% sol./30% isoph.)
    Novo Nordisk, Austria; Novo Nordisk, Australia; Novo Nordisk, Belgium; Novo Nordisk, Denmark; Novo Nordisk, Spain; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Israel; Novo Nordisk, Italy; Novo Nordisk, Lithuania; Novo Nordisk, Netherlands
  • NovoRapid 30 Mix (30% aspart sol./70% aspart isoph.)
    Novo Nordisk, Japan
  • NovoRapid 50 Mix (50% aspart sol./50% aspart isoph.)
    Novo Nordisk, Japan
  • NovoRapid 70 Mix (70% aspart sol./30% aspart isoph.)
    Novo Nordisk, Japan

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide